NCT05101811

Vitamin D Levels in Women With Polycystic Ovary Syndrome

Assessment of Serum Vitamin D Levels in Women With Polycystic Ovary Syndrome

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Ghamra Military Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 35 Years
• Healthy volunteers: Accepted

Summary

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%. Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Detailed description

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome \& healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Conditions

• Polycystic Ovary Syndrome

Interventions

Type	Name	Description
DRUG	Vitamin D Levels measurement using chemiluminescent assay	Measurement of serum vitamin D levels
DEVICE	Vitamin D level assessment	Using lIAISON DEVICE

Timeline

• Start date: 2020-05-01
• Primary completion: 2021-04-01
• Completion: 2021-05-01
• First posted: 2021-11-01
• Last updated: 2021-11-01

Locations

1 site across 1 country: Egypt

Regulatory

• FDA-regulated drug study
• FDA-regulated device study